FDA Targets Executives With Powerful Misdemeanor Strategy
This article was originally published in The Tan Sheet
Executive Summary
Executives could face virtually unbeatable government criminal prosecutions and prison sentences more frequently if FDA follows recently announced enforcement plans, industry attorneys warn